✦ LIBER ✦

P-513 The efficacy and safety of padexol (paclitaxel) and cisplatin in advanced non-small cell lung cancer

✍ Scribed by Kim, H.; Kim, J.; Ryoo, H.; Shin, D.; Kim, C.; Park, K.; Bae, S.; Shim, B.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel and cisplatin in advanced non

📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Paclitaxel plus cisplatin in the treatme

✍ Tong Maorong; Cao Ehong; Xia Xirong; Shi Yi; Kang Xiaoming 📂 Article 📅 1996 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 149 KB

Pharmacoeconomic analysis of advanced no

✍ C. Rubio-Terrés; J.L. Tisaire; S. Kobina; A. Moyano 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 351 KB

Cost-effectiveness of paclitaxel plus ci

✍ Earle, C C; Evans, W K 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 84 KB

Pharmacology of the paclitaxel–cisplatin

✍ J. R. Kroep; E. F. Smit; G. Giaccone; K. Van der Born; J. H. Beijnen; C. J. Van 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 248 KB

Efficacy and safety of weekly nab-paclit

✍ Satouchi, Miyako; Okamoto, Isamu; Sakai, Hiroshi; Yamamoto, Nobuyuki; Ichinose, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 376 KB